Document ID: chunk:federal_register_of_legislation:F2024C00880:reg:24:p4
Version: federal_register_of_legislation:F2024C00880
Segment Type: reg
Provision Reference: reg 24 (pt 4/5)
Character Range: 47187–50646

1 Nov 2017 (s 2)                                  —
National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2018 (No. 1) (PB 28 of 2018)                      28 Mar 2018 (F2018L00429)   1 Apr 2018 (s 2)                                  —
National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2018 (No. 2) (PB 35 of 2018)                      30 Apr 2018 (F2018L00548)   1 May 2018 (s 2)                                  —
National Health (Growth Hormone Program) Special Arrangement Amendment (Adult Use) Instrument 2018 (PB 96 of 2018)                  29 Nov 2018 (F2018L01634)   1 Dec 2018 (s 2(1) item 1)                        —
National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2018 (No. 3) (PB 113 of 2018)                     20 Dec 2018 (F2018L01815)   1 Jan 2019 (s 2)                                  —
National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2019 (No. 1) (PB 22 of 2019)                      28 Mar 2019 (F2019L00452)   1 Apr 2019 (s 2)                                  —
National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2019 (No. 2) (PB 80 of 2019)                      30 Sept 2019 (F2019L01299)  1 Oct 2019 (s 2)                                  —
National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2019 (No. 3) (PB 109 of 2019)                     20 Dec 2019 (F2019L01679)   1 Jan 2020 (s 2(1) item 1)                        —
National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2020 (No. 1) (PB 6 of 2020)                       31 Jan 2020 (F2020L00071)   1 Feb 2020 (s 2)                                  —
National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2021 (No. 1) (PB 44 of 2021)                      30 Apr 2021 (F2021L00528)   1 May 2021 (s 2)                                  —
National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2021 (No. 2) (PB 52 of 2021)                      28 May 2021 (F2021L00664)   1 June 2021 (s 2)                                 —
National Health (Growth Hormone Program) Special Arrangement Amendment (Mecasermin and Somatrogon) Instrument 2022 (PB 92 of 2022)  26 Sept 2022 (F2022L01250)  1 Oct 2022 (s 2(1) item 1)                        —
National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2022 (No. 1) (PB 93 of 2022)                      30 Sept 2022 (F2022L01307)  1 Oct 2022 (s 2(1) item 1)                        —
National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2023 (No. 1). (PB 16 of 2023)                     28 Feb 2023 (F2023L00167)   1 Mar 2023 (s 2(1) item 1)                        —
National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2023 (No. 2) (PB 96 of 2023)                      29 Sept 2023 (F2023L01336)  1 Oct 2023 (s 2(1) item 1)                        —
National Health Legislation (Repeal and Consequential Amendments) Instrument 2024 (PB 36 of 2024)                                   28 Mar 2024 (F2024L00412)   Sch 2 (items 23, 24): 1 Apr 2024 (s 2(1) item 1)  —
National Health Legislation Amendment (Extension of Closing the Gap – PBS Co‑payment Program) Instrument 2024 (PB 66 of 2024)       27 June 2024 (F2024L00803)  Sch 1 (items 29–33): 1 July 2024 (s 2(1) item 2)  —
National Health